Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Buy

Debt to Equity Rating

Buy

Price to Earnings Rating

Sell

Analyst Rating

Buy

Upgrade To View Simple Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Exponential Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Relative Strength Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Standard Deviation Rating

Upgrade

Upgrade To Get Access

Upgrade To View Williams %R Rating

Upgrade

Upgrade To Get Access

Upgrade To View Average Directional Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Insider Trading Rating

Upgrade

Upgrade To Get Access

Wall Street Data Solutions Rating

Neutral

B

MiMedx Group, Inc (MDXG)

Surgical & Medical Instruments & Apparatus

https://www.mimedx.com

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, MiMedx sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

1775 W OAK COMMONS COURT, NE
MARIETTA, GA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

02/12/2008

Market Cap

922,694,565

Shares Outstanding

116,380,000

Weighted SO

146,376,583

Total Employees

N/A

Upcoming Earnings

07/31/2024

Similar Tickers

GLUE --.--%

DSGN --.--%

HOWL --.--%

IKNA --.--%

STOK --.--%

IPSC --.--%

EWTX --.--%

CCCC --.--%

MLYS --.--%

Beta

1.9810

Last Div

0.0000

Range

5.57-9.27

Chg

0.0150

Avg Vol

719438

Mkt Cap

922694565

Exch

NASDAQ

Country

US

Phone

770 651 9100

DCF Diff

7.2656

DCF

-1.0156

Div Yield

0.0000

P/S

2.7101

EV Multiple

11.7457

P/FV

5.5103

Div Yield %

0.0000

P/E

9.6117

PEG

3.5847

Payout

0.0000

Current Ratio

3.8493

Quick Ratio

3.2231

Cash Ratio

1.7254

DSO

56.6036

DIO

160.8612

Op Cycle

217.4648

DPO

48.8118

CCC

168.6530

Gross Margin

0.8330

Op Margin

0.2186

Pretax Margin

0.2029

Net Margin

0.2830

Eff Tax Rate

-0.4176

ROA

0.4185

ROE

0.8237

ROCE

0.3913

NI/EBT

1.3949

EBT/EBIT

0.9282

EBIT/Rev

0.2186

Debt Ratio

0.0836

D/E

0.1146

LT Debt/Cap

0.0980

Total Debt/Cap

0.1028

Int Coverage

14.9835

CF/Debt

2.5840

Equity Multi

1.3698

Rec Turnover

6.4484

Pay Turnover

7.4777

Inv Turnover

2.2690

FA Turnover

34.0562

Asset Turnover

1.4791

OCF/Share

0.3376

FCF/Share

0.3193

Cash/Share

0.4686

OCF/Sales

0.1461

FCF/OCF

0.9459

CF Coverage

2.5840

ST Coverage

49.7390

CapEx Coverage

18.4697

Div&CapEx Cov

18.4697

P/BV

5.5103

P/B

5.5103

P/S

2.7101

P/E

9.6117

P/FCF

19.6126

P/OCF

18.6161

P/CF

18.6161

PEG

3.5847

P/S

2.7101

EV Multiple

11.7457

P/FV

5.5103

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Dec 29, 17:00 MIMEDX Provides AXIOFILL® Update & Reiterates 2023 Full Year Net Sales and Fourth Quarter Adjusted EBITDA Margin Outlook

Revenue Product Segmentation